H.R. 6483 — Improved Transparency of Foreign Drug Manufacturing Act of 2022

“To amend the Federal Food, Drug, and Cosmetic Act to clarify reporting requirements for establishments within a foreign country engaged in the manufacture, preparation, propagation, compounding, or processing of an active pharmaceutical ingredient, and for other purposes.”